Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445848
Status:
COMPLETED
Last Update Posted:
2020-03-05
First Post:
2007-03-07
Brief Title:
S0636 Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Organization Data
Organization:
SWOG Cancer Research Network
Class:
NETWORK
Study ID:
CDR0000531056
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SWOG Cancer Research Network
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |